-
公开(公告)号:US11723621B2
公开(公告)日:2023-08-15
申请号:US16986730
申请日:2020-08-06
Applicant: Edwards Lifesciences Corporation
Inventor: Yaron Keidar
IPC: A61B5/02 , A61B8/06 , A61B8/00 , A61B5/0245 , A61B5/0205 , A61B5/00 , A61B8/08 , A61B5/113 , A61B8/04 , A61B5/08 , A61B5/021 , A61B5/022 , A61B7/00 , A61B8/02
CPC classification number: A61B8/065 , A61B5/0022 , A61B5/0205 , A61B5/0245 , A61B5/113 , A61B5/746 , A61B8/04 , A61B8/06 , A61B8/0833 , A61B8/0883 , A61B8/4236 , A61B8/4281 , A61B8/4427 , A61B8/4455 , A61B8/4472 , A61B8/4477 , A61B8/4494 , A61B8/488 , A61B8/5223 , A61B8/565 , A61B8/585 , A61B5/021 , A61B5/022 , A61B5/0816 , A61B7/003 , A61B8/02 , A61B8/085 , A61B8/0841 , A61B8/4488 , A61B8/58 , A61B2505/07 , A61B2560/0214 , A61B2560/0223 , A61B2562/0219
Abstract: A monitoring system includes a wearable patch device configured to be secured to a body of a patient, the wearable patch device comprising a patch body, a first discrete transducer associated with a first position of the patch body, a second discrete transducer associated with a second portion of the patch body, and a wireless transmitter, and electronics including one or more processors and one or more memory devices and configured to receive signals based on transducer readings of the first and second discrete transducers and determine an amount of blood flow through one or more valves of a heart of the patient based on the signals.
-
公开(公告)号:US11690590B2
公开(公告)日:2023-07-04
申请号:US16177609
申请日:2018-11-01
Applicant: Edwards Lifesciences Corporation
Inventor: Yaron Keidar
CPC classification number: A61B8/06 , A61B5/6823 , A61B7/023 , A61B8/08 , A61B8/4427 , A61B8/4455 , A61B8/488 , A61B8/5223 , A61B8/56 , A61B8/0883 , A61B8/4488
Abstract: The invention is a device, system, and method for providing an initial assessment of potential heart valve disease and recommending and/or providing follow-up assessments for heart valve disease. The invention includes a simple ECHO device which uses ultrasonic signals to detect and determine maximum blood flow velocities, and compares the maximum blood flow velocities to set thresholds to determine if it is appropriate for the patient to be subjected to additional and more detailed assessments for heart valve disease.
-
公开(公告)号:US11478351B2
公开(公告)日:2022-10-25
申请号:US16934401
申请日:2020-07-21
Applicant: Edwards Lifesciences Corporation
Inventor: Stanton J. Rowe , Yaron Keidar
IPC: A61F2/24
Abstract: Embodiments of a heart shape preserving anchor are disclosed herein. The heart shape preserving anchor can include a frame having one or more wings extending from a lower end of the frame. The frame can be sized and shaped to distribute forces over a large surface area thereby reducing pressures applied on the heart. The anchor can include a tether for coupling to a prosthesis, such as a replacement heart valve prosthesis. In some embodiments, the anchor can include a tether adjustment mechanism which can be wirelessly operated to adjust a length of the tether relative to the frame.
-
公开(公告)号:US10667904B2
公开(公告)日:2020-06-02
申请号:US15452617
申请日:2017-03-07
Applicant: Edwards Lifesciences Corporation
Inventor: Salvador Marquez , Da-Yu Chang , Cindy Woo , Hao-Chung Yang , Lynn T. Dang , Javier A. Sanguinetti , Alexander H. Siemons , Yaron Keidar , Virginia Qi Lin , Brian S. Conklin , Donald E. Bobo, Jr.
Abstract: Sensor-integrated prosthetic valves that can comprise a variety of features, including a plurality of valve leaflets, a frame assembly configured to support the plurality of valve leaflets and define a plurality of commissure supports terminating at an outflow end of the prosthetic valve, a sensor device associated with the frame assembly and configured to generate a sensor signal, for example, a sensor signal indicating deflection of one or more of the plurality of commissure supports, and a transmitter assembly configured to receive the sensor signal from the sensor device and wirelessly transmit a transmission signal that is based at least in part on the sensor signal.
-
公开(公告)号:US20200054450A1
公开(公告)日:2020-02-20
申请号:US16666099
申请日:2019-10-28
Applicant: Edwards Lifesciences Corporation
Inventor: Stanton J. Rowe , Larry L. Wood , Henry Bourang , George Bakis , Benjamin Spenser , Netanel Benichou , Assaf Bash , Yaron Keidar
Abstract: A two-stage or component-based valve prosthesis that can be quickly and easily implanted during a surgical procedure is provided. The prosthetic valve comprises a support structure that is deployed at a treatment site. The prosthetic valve further comprises a valve member configured to be quickly connected to the support structure. The support structure may take the form of a stent that is expanded at the site of a native valve. If desired, the native leaflets may remain and the stent may be used to hold the native valve open. In this case, the stent may be balloon expandable and configured to resist the powerful recoil force of the native leaflets. The support structure is provided with a coupling means for attachment to the valve member, thereby fixing the position of the valve member in the body. The valve member may be a non-expandable type, or may be expandable from a compressed state to an expanded state. The system is particularly suited for rapid deployment of heart valves in a conventional open-heart surgical environment.
-
公开(公告)号:US10456251B2
公开(公告)日:2019-10-29
申请号:US16298616
申请日:2019-03-11
Applicant: Edwards Lifesciences Corporation
Inventor: Stanton J. Rowe , Larry L. Wood , Henry Bourang , George Bakis , Benjamin Spenser , Netanel Benichou , Assaf Bash , Yaron Keidar
Abstract: A two-stage or component-based valve prosthesis that can be quickly and easily implanted during a surgical procedure is provided. The prosthetic valve comprises a support structure that is deployed at a treatment site. The prosthetic valve further comprises a valve member configured to be quickly connected to the support structure. The support structure may take the form of a stent that is expanded at the site of a native valve. If desired, the native leaflets may remain and the stent may be used to hold the native valve open. In this case, the stent may be balloon expandable and configured to resist the powerful recoil force of the native leaflets. The support structure is provided with a coupling means for attachment to the valve member, thereby fixing the position of the valve member in the body. The valve member may be a non-expandable type, or may be expandable from a compressed state to an expanded state. The system is particularly suited for rapid deployment of heart valves in a conventional open-heart surgical environment.
-
公开(公告)号:US10376681B2
公开(公告)日:2019-08-13
申请号:US15335054
申请日:2016-10-26
Applicant: Edwards Lifesciences Corporation
Inventor: Gregory Bak-Boychuk , Yaron Keidar , Bingquan Su
Abstract: A compliance restoration device includes a compliance balloon lumen, a chamber support structure disposed in the compliance balloon lumen and configured to expand to support an expanded volume of the compliance balloon lumen, and a spring assembly configured to cause the chamber support structure to expand by applying a force on a first end of the chamber support structure.
-
8.
公开(公告)号:US10231834B2
公开(公告)日:2019-03-19
申请号:US15018781
申请日:2016-02-08
Applicant: Edwards Lifesciences Corporation
Inventor: Yaron Keidar
IPC: A61F2/24 , A61B17/064
Abstract: A low profile transseptal catheter and implant system is disclosed. Access to the mitral valve can be obtained using femoral catheterization with a fluoroscopically guided, low-profile catheter. For example, the right atrium is accessed and the interatrial septum punctured to access the left atrium, and the mitral valve is approached through the left atrium. Advantageously, this approach avoids contact with the left ventricular outflow tract and the chordae tendinae. Two leaflet braces are extended over guide wires to form semicircular loops that circumnavigate the anterior and posterior mitral valve leaflets. Tension is applied to the catheter from the atrial direction to keep the leaflet braces tightly wedged under the leaflets for the remainder of the procedure. A fastener joins the ends of each loop to create one annular ring encircling the valve under the anterior and posterior leaflets.
-
公开(公告)号:US20150105856A1
公开(公告)日:2015-04-16
申请号:US14571141
申请日:2014-12-15
Applicant: Edwards Lifesciences Corporation
Inventor: Stanton J. Rowe , Larry L. Wood , Henry Bourang , George Bakis , Benjamin Spenser , Netanel Benichou , Assaf Bash , Yaron Keidar
CPC classification number: A61F2/2418 , A61F2/2409 , A61F2/2412 , A61F2/2445 , A61F2/90 , A61F2220/0008 , A61F2220/0016 , A61F2220/0025 , A61F2220/0041 , A61F2220/0066 , A61F2220/0075 , A61F2220/0083 , A61F2230/0078 , A61F2250/006 , A61F2250/0098 , A61L27/3625
Abstract: A heart valve prosthesis that can be quickly and easily implanted during a surgical procedure is provided. The prosthetic valve comprises a support structure that is deployed at a treatment site. The prosthetic valve further comprises a valve member configured to be quickly connected to the support structure. The support structure may take the form of a stent that is expanded at the site of a native valve. If desired, the native leaflets may remain and the stent may be used to hold the native valve open. In this case, the stent may be balloon expandable and configured to resist the powerful recoil force of the native leaflets. The support structure is provided with a coupling means for attachment to the valve member, thereby fixing the position of the valve member in the body. The valve member may be expandable or a non-expandable type.
Abstract translation: 提供了可以在手术过程中快速且容易地植入的心脏瓣膜假体。 假体瓣膜包括部署在治疗部位的支撑结构。 假体瓣膜还包括构造成快速连接到支撑结构的阀构件。 支撑结构可以采取在天然瓣膜部位扩张的支架的形式。 如果需要,天然传单可以保留,并且支架可以用于保持天然瓣膜打开。 在这种情况下,支架可以是球囊可扩张的并且被配置为抵抗天然传单的强大后坐力。 支撑结构设置有用于附接到阀构件的联接装置,从而将阀构件的位置固定在主体中。 阀构件可以是可膨胀型或不可膨胀型。
-
公开(公告)号:US20130317598A1
公开(公告)日:2013-11-28
申请号:US13954822
申请日:2013-07-30
Applicant: Edwards Lifesciences Corporation
Inventor: Stanton J. Rowe , Larry L. Wood , Henry Bourang , George Bakis , Benjamin Spenser , Netanel Benichou , Assaf Bash , Yaron Keidar
IPC: A61F2/24
CPC classification number: A61F2/2418 , A61F2/2409 , A61F2/2412 , A61F2/2445 , A61F2/90 , A61F2220/0008 , A61F2220/0016 , A61F2220/0025 , A61F2220/0041 , A61F2220/0066 , A61F2220/0075 , A61F2220/0083 , A61F2230/0078 , A61F2250/006 , A61F2250/0098 , A61L27/3625
Abstract: A heart valve prosthesis that can be quickly and easily implanted during a surgical procedure is provided. The prosthetic valve comprises a support structure that is deployed at a treatment site. The prosthetic valve further comprises a valve member configured to be quickly connected to the support structure. The support structure may take the form of a stent that is expanded at the site of a native valve. If desired, the native leaflets may remain and the stent may be used to hold the native valve open. In this case, the stent may be balloon expandable and configured to resist the powerful recoil force of the native leaflets. The support structure is provided with a coupling means for attachment to the valve member, thereby fixing the position of the valve member in the body. The valve member may be expandable or a non-expandable type.
Abstract translation: 提供了可以在手术过程中快速且容易地植入的心脏瓣膜假体。 假体瓣膜包括部署在治疗部位的支撑结构。 假体瓣膜还包括构造成快速连接到支撑结构的阀构件。 支撑结构可以采取在天然瓣膜部位扩张的支架的形式。 如果需要,天然传单可以保留,并且支架可以用于保持天然瓣膜打开。 在这种情况下,支架可以是球囊可扩张的并且被配置为抵抗天然传单的强大后坐力。 支撑结构设置有用于附接到阀构件的联接装置,从而将阀构件的位置固定在主体中。 阀构件可以是可膨胀型或不可膨胀型。
-
-
-
-
-
-
-
-
-